Kristen Treleven, DPM
Primary Podiatric Medicine · Greeley, CONPI 1558925362
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Gemini Mountain Medical, LLC at 41.1% of the total. Reporting peaked in 2020 at $3,044 and has fallen 53.1% since, to $1,428 in 2025.
Across 90 payments — averaging $79.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gemini Mountain Medical, LLC$3K
- Paragon 28, Inc.$888
- Smith+Nephew$796
- Treace Medical Concepts, Inc.$766
- Amgen$419
- Pylant Medical$213
- plus $1K from 14 others
What the payments were for
- Travel & lodging$3325%
- Food & beverage$3,87554%
- Education$2,93941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gemini Mountain Medical, LLC | 2 | $2,939 |
| Paragon 28, Inc. | 3 | $888 |
| Smith+Nephew | 15 | $796 |
| Treace Medical Concepts, Inc. | 17 | $766 |
| Amgen(2 entities) | 7 | $419 |
| Pylant Medical | 3 | $213 |
| Averitas Pharma Inc. | 2 | $170 |
| Orthofix Medical, Inc. | 18 | $158 |
| Osteoremedies, LLC | 1 | $153 |
| Pacira Pharmaceuticals Incorporated | 2 | $149 |
| Stryker | 4 | $111 |
| Paratek Pharmaceuticals, Inc. | 5 | $101 |
| Convatec Inc. | 1 | $85 |
| IBSA Pharma Inc. | 4 | $64 |
| Johnson & Johnson | 1 | $39 |
| Heron Therapeutics, Inc. | 1 | $25 |
| Vertex | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Nevro Corp. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$739
- KRYSTEXXA$390
- TMC NANOPLASTY SYSTEM$300
- Stravix$218
- BlastX$153
- Xperience$153
- Portfolio$149
- Qutenza$140
- Bone Anchors with Arthroscopic Delivery System$139
- Lapiplasty System$124
- EXPAREL$118
- Allevyn Life$104
- GRAFIX PL$104
- PICO7$104
- Santyl$104
How this compares
Too few primary podiatric medicine providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 16 | $10,012 |
| CiclopiroxCiclopirox Olamine | 166 | $3,333 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 51 | $463 |
| Betamethasone Valerate | 22 | $430 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Greeley
- Hani SaeedDenver$2K
- Kevin DericksonDenver$2K
- Jennifer YullColorado Springs$1K
- Frederick MechanikDenver$1K
- Michael ThomasFort Collins$669
- Garrett MooreDenver$410
- Stephen AlbertDenver$76
- Edward RaczkaDenver$67
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.